Beyond chromatin accessibility: bulk ATAC-seq as an integrative assay to portray genomes and epigenomes
NAR Genomics and Bioinformatics · 2026
DOI: 10.1093/nargab/lqag046 ↗Kurz gefasst
Fachartikel in der Zeitschrift NAR Genomics and Bioinformatics, 2026. Verfasst von Islem Toumi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institut de Recherche en Cancérologie de Montpellier (IRCM), INSERM U1194, Univ. Montpellier, Institut régional du Cancer de Montpellier (ICM), 34298…. Hauptthemen laut MEDLINE: Chromatin, Epigenome, Epigenomics, Chromatin Immunoprecipitation Sequencing. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ligue Contre le Cancer, ARC, Institut National contre le Cancer.
Abstract (Originalsprache)
Assay for transposase-accessible chromatin using sequencing (ATAC-seq) is a cornerstone for epigenomic profiling, yet its potential for genomic characterization remains poorly explored. Here, we systematically benchmarked bulk ATAC-seq against whole-genome sequencing (WGS) to assess its capacity for detecting small variants, copy number variations (CNVs), telomere-associated repeat content, and mitochondrial single-nucleotide polymorphisms in cancer cells. Using paired datasets from patient-derived melanoma cell lines and from TCGA primary brain tumors, we demonstrated that ATAC-seq achieves high precision in small variants detection within accessible regions supporting cohort-scale genotyping and genetic stratification, robustly resolves CNVs in the nuclear genome, and supports high-coverage mitogenome profiling, with strong concordance to WGS at standard sequencing depths. Notably, we present the first systematic evaluation of telomere-associated repeat content by ATAC-seq, revealing its untapped potential for studying genome stability. By bridging genomic and epigenomic insights into a single genome-wide approach, bulk ATAC-seq emerges as a cost-effective and versatile tool poised to transform cancer research and to support integrative molecular profiling in clinical settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institut de Recherche en Cancérologie de Montpellier (IRCM), INSERM U1194, Univ. Montpellier, Institut régional du Cancer de Montpellier (ICM), 34298 Montpellier, France.
- Equipe labélisée Ligue Contre le Cancer, 75013 Paris, France.
ORCID-Profile: Pierre-François Roux
Förderung
- Ligue Contre le Cancer
- ARC
- Institut National contre le Cancer
- Fondation pour la Recherche Médicale
- Inserm
Zitieren
APA
Toumi, I., Kham, C., Stuani, L., Le Cam, L., & Roux, P. F. (2026). Beyond chromatin accessibility: bulk ATAC-seq as an integrative assay to portray genomes and epigenomes. NAR Genomics and Bioinformatics. https://doi.org/10.1093/nargab/lqag046
Vancouver
Toumi I, Kham C, Stuani L, Le Cam L, Roux PF. Beyond chromatin accessibility: bulk ATAC-seq as an integrative assay to portray genomes and epigenomes. NAR Genomics and Bioinformatics. 2026. doi:10.1093/nargab/lqag046
BibTeX
@article{Toumi2026,
author = {Toumi, Islem and Kham, Chaimae and Stuani, Lucille and Le Cam, Laurent and Roux, Pierre-François},
title = {Beyond chromatin accessibility: bulk ATAC-seq as an integrative assay to portray genomes and epigenomes},
journal = {NAR Genomics and Bioinformatics},
year = {2026},
doi = {10.1093/nargab/lqag046}
}
EUVIMED